Cambodia vs Indonesia: New cases tested for RR-/MDR-TB
Cambodia
94.0%
in 2024
Indonesia
94.0%
in 2024
Cambodia rank
76th
Indonesia rank
76th
New cases tested for RR-/MDR-TB over time
- Cambodia
- Indonesia
How they compare
Cambodia currently reports 94.0% against 94.0% in Indonesia, a difference of 0.0%.
The two have swapped places 3 times across 9 shared years of data; in 2010 it was Cambodia ahead.
Cambodia ranks 76th and Indonesia ranks 76th of 192 countries.
Cambodia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Indonesia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 0.7% | 1.3% | Cambodia |
| 2020s | 83.5% | 76.0% | 7.5% | Cambodia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Cambodia or Indonesia?
- Cambodia, at 94.0% against 94.0% in Indonesia as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Cambodia and Indonesia?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Indonesia?
- 9 years are reported by both, from 2010 to 2024.
- How do Cambodia and Indonesia rank globally for new cases tested for rr-/mdr-tb?
- Cambodia ranks 76th and Indonesia ranks 76th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.